Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Amortizatization of Intangibles (2018 - 2022)

Spero Therapeutics' Amortizatization of Intangibles history spans 5 years, with the latest figure at $10000.0 for Q2 2022.

  • For Q2 2022, Amortizatization of Intangibles rose 116.67% year-over-year to $10000.0; the TTM value through Mar 2023 reached $10000.0, up 104.76%, while the annual FY2022 figure was -$13000.0, 94.82% up from the prior year.
  • Amortizatization of Intangibles reached $10000.0 in Q2 2022 per SPRO's latest filing, up from -$23000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $355000.0 in Q1 2019 to a low of -$73000.0 in Q3 2021.
  • Average Amortizatization of Intangibles over 5 years is $66055.6, with a median of $27500.0 recorded in 2018.
  • Peak YoY movement for Amortizatization of Intangibles: soared 688.89% in 2019, then crashed 3550.0% in 2021.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $325000.0 in 2018, then crashed by 73.23% to $87000.0 in 2019, then crashed by 128.74% to -$25000.0 in 2020, then crashed by 116.0% to -$54000.0 in 2021, then surged by 118.52% to $10000.0 in 2022.
  • Per Business Quant, the three most recent readings for SPRO's Amortizatization of Intangibles are $10000.0 (Q2 2022), -$23000.0 (Q1 2022), and -$54000.0 (Q4 2021).